D59.9, Acquired hemolytic anemia, unspecifiedICD-10-CM
No Prior Auth Required
Covered without prior authorization (high confidence)
CGS-J15-L38249, MolDX: Blood Product Molecular Antigen Typing
J15
CGS-J18-L38249, MolDX: Blood Product Molecular Antigen Typing
J18
A57110, Billing and Coding: MolDX: Blood Product Molecular Antigen Typing
J5
WPS-J5-L38441, MolDX: Blood Product Molecular Antigen Typing
J5
Ask Backwork about documentation requirements, denial risks, or coverage in your state.
J6
NGS-J6-L39297, Off-label Use of Rituximab and Rituximab Biosimilars
J6
NGS-J6-L39314, Off-Label Use of Intravenous Immune Globulin (IVIG)
J6
A59101, Billing and Coding: Off-label Use of Rituximab and Rituximab Biosimilars
J6
WPS-J8-L38441, MolDX: Blood Product Molecular Antigen Typing
J8
NGS-JK-L39314, Off-Label Use of Intravenous Immune Globulin (IVIG)
JK
NGS-JK-L39297, Off-label Use of Rituximab and Rituximab Biosimilars
JK
AETNA-CPB-0675, Bortezomib Products
A55717, Billing and Coding: Lab: Flow Cytometry
A56718, Billing and Coding: Intravenous Immunoglobulin (IVIG)
CIGNA-0538, Flow Cytometry
A57124, Billing and Coding: MolDX: Blood Product Molecular Antigen Typing
A57155, Billing and Coding: MolDX: Blood Product Molecular Antigen Typing
A57689, Billing and Coding: Lab: Flow Cytometry
A58308, Billing and Coding: MolDX: Blood Product Molecular Antigen Typing
ANTHEM-CG-LAB-19, Laboratory Evaluation of Vitamin B12